For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome

Hello. We're improving abcam.com and we'd welcome your feedback.

Hello. We're improving abcam.com and we'd welcome your feedback.

Infomation icon

We haven't added this to the BETA yet

New BETA website

New BETA website

Hello. We're improving abcam.com and we'd welcome your feedback.

Take a look at our BETA site and see what we’ve done so far.

Switch on our new BETA site

Now available

Search and browse selected products

  • A selection of primary antibodies

Purchase these through your usual distributor

In the coming months

  • Additional product types
  • Supporting content
  • Sign in to your account
  • Purchase online
United States
Your country/region is currently set to:

If incorrect, please enter your country/region into the box below, to view site information related to your country/region.

Call (888) 77-ABCAM (22226) or contact us
Need help? Contact us

  • My account
  • Sign out
Sign in or Register with us

Welcome

Sign in or

Don't have an account?

Register with us
My basket
Quick order
Abcam homepage

  • Research Products
    By product type
    Primary antibodies
    Secondary antibodies
    ELISA and Matched Antibody Pair Kits
    Cell and tissue imaging tools
    Cellular and biochemical assays
    Proteins and Peptides
    By product type
    Proteomics tools
    Agonists, activators, antagonists and inhibitors
    Cell lines and Lysates
    Multiplex miRNA assays
    Multiplex Assays
    By research area
    Cancer
    Cardiovascular
    Cell Biology
    Epigenetics
    Metabolism
    Developmental Biology
    By research area
    Immunology
    Microbiology
    Neuroscience
    Signal Transduction
    Stem Cells
  • Customized Products & Partnerships
    Customized Products & Partnerships

    Customized products and commercial partnerships to accelerate your diagnostic and therapeutic programs.

    Customized products

    Partner with us

  • Support
    Support hub

    Access advice and support for any research roadblock

    View support hub

    Protocols

    Your experiments laid out step by step

    View protocols

  • Events
    • Conference calendar
    • Cancer
    • Cardiovascular
    • Epigenetics & Nuclear signaling
    • Immunology
    • Neuroscience
    • Stem cells
    • Tradeshows
    • Scientific webinars
    Keep up to date with the latest events

    Full event breakdown with abstracts, speakers, registration and more

    View global event calendar

  • Pathways
    Cell signalling pathways

    View all pathways

    View all interactive pathways

PD-L1

Related

  • Browse by target
    • PD-1/PD-L1 pathway

      ​

      PD-L1 (programmed cell death 1 ligand 1) is a protein encoded by the CD274 gene. PD-L1 binds to its receptor, PD-1, to modulate immune activation or inhibition and is a target in cancer immunotherapy.

      ​Overview

      • Protein function, expression, and isoforms
      • Application-specific tips for working with PD-L1
      • References

      ​​Protein function, expression, and isoforms

      Protein function:

      • PD-L1 plays a critical role in induction and maintenance of immune tolerance to self and, as a ligand for the inhibitory receptor PDCD1/PD-1, modulates the activation threshold & limits the effector response of T-cells. 1 2 3 
      • Through a yet unknown activating receptor, PD-L1 may co-stimulate T-cell subsets that predominantly produce interleukin-10 (IL10). 4
      • The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and escape destruction by the immune system, thereby facilitating tumor survival. 2 3
      Expression

      PD-L1 is highly expressed in the heart, skeletal muscle, placenta and lung, and is weakly expressed in the thymus, spleen, kidney and liver
      PD-L1 is also expressed on activated T- and B-cells, dendritic cells, keratinocytes and monocytes 4 1
      PD-L1 is up-regulated on T- and B-cells, dendritic cells, keratinocytes and monocytes after LPS and IFNG activation
      It is also up-regulated in B-cells activated by surface Ig cross-linking 4 1 3

      Expression

      • PD-L1 is highly expressed in the heart, skeletal muscle, placenta, and lung, and is weakly expressed in the thymus, spleen, kidney, and liver
      • PD-L1 is also expressed on activated T- and B-cells, dendritic cells, keratinocytes, and monocytes 4 1
      • PD-L1 is up-regulated on T- and B-cells, dendritic cells, keratinocytes, and monocytes after LPS and IFNG activation
      • It is also up-regulated in B-cells activated by surface Ig cross-linking 4 1 3

      Isoforms

      • Human: Isoform I-3: 20-33kD (predicted)
      • Mouse: 32.8kD (predicted)

      ​​​​Applications

      PD-L1 can be a challenging target to work with in some applications. 

      Western blot

      PD-L1 is heavily glycosylated, therefore the actual band size in western blot is between 40-60kD, different from the predicted 20-33kD. 



      Sample preparation

      Add adequate protease inhibitors (or phosphatase inhibitors for proteins modified by phosphorylation) to avoid target protein degradation.


      Ultrasonicate samples to enrich more target proteins

      Keep samples on ice during the whole WB process

      Perform a Bradford assay, a Lowry assay, or a bicinchoninic acid (BCA) assay to determine the protein concentration
      ElectrophoresisLoad 20-50μg total protein per lane.
      TransferringUse Ponceau S staining to determine if the transfer is successful
      Maximizing signalsTreat samples with PNGase F to confirm the specificity of bands if necessary. 5

      Actual band size in Western Blot is between 40-60kD.
      ControlsPositive: 
      B-CPAP, MD-MB-231, U87-MG
      Negative: 
      A549 SW480









      Immunohistochemistry

      PD-L1 is highly expressed in lung, ovary, and colon carcinoma and in melanomas. However, not all samples show a positive signal, and the glycosylation of PD-L1 may interfere with antibody binding.



      Sample preparation The ideal fixation time will depend on the size of the tissue block and the type of tissue, but fixation between 18–24h is suitable for most samples.

      Under-fixation can lead to edge staining, with a strong signal on the edges of the section and no signal in the middle.

      Over-fixation can mask the epitope. Antigen retrieval can help reverse this masking, but if the tissue has been fixed for a long period of time (ie over a weekend), there may be no signal even after antigen retrieval.
      Antibody incubationIt is recommended to optimize antibody dilution in preliminary experiments according to datasheets.
      Maximizing signalTreat samples with PNGase F may increase signal intensity.5

      To find PD-L1 expression in lung cancer tissues, please refer to the table here (PD-L1 IHC 28-8 pharmDx, Dako). For PD-L1 expression in other tumors, please refer to: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3991103/
      ControlsPositive: 
      Human tonsil, head, and neck squamous cell carcinoma
      Placenta tissues
      Negative:
      MCF-7 5

      Find full information on working with PD-L1: 

      • In English 
      • In Mandarin

      ​​References

      1. Freeman, GJ., Long, AJ., Iwai, Y., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 192 (7), 1027-34 (2000)
      2. Burr, ML., Sparbier, CE., Chan, YC., et al. CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity. Nature. 549, 101-105 (2017)
      3. Mezzadra, R., Sun, C., Jae, LT., et al. Identification of CMTM6 and CMTM4 as PD-L1 protein regulators. Nature. 549, 106-110 (2017)
      4. Dong, H., Zhu, G., Tamada, K., Chen, L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med. 5, 1365-9 (1999)
      5. Lee, HH., Wang, YN., Xia ,W., et al. Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy. Cancer Cell. 36, 168-178 (2019)




      Get resources and offers direct to your inbox Sign up
      A-Z by research area
      • Cancer
      • Cardiovascular
      • Cell biology
      • Developmental biology
      • Epigenetics & Nuclear signaling
      • Immunology
      • Metabolism
      • Microbiology
      • Neuroscience
      • Signal transduction
      • Stem cells
      A-Z by product type
      • Primary antibodies
      • Secondary antibodies
      • Biochemicals
      • Isotype controls
      • Flow cytometry multi-color selector
      • Kits
      • Loading controls
      • Lysates
      • Peptides
      • Proteins
      • Slides
      • Tags and cell markers
      • Tools & Reagents
      Help & support
      • Support
      • Make an Inquiry
      • Protocols & troubleshooting
      • Placing an order
      • RabMAb products
      • Biochemical product FAQs
      • Training
      • Browse by Target
      Company
      • Corporate site
      • Investor relations
      • Company news
      • Careers
      • About us
      • Blog
      Events
      • Tradeshows
      • Conferences
      International websites
      • abcam.cn
      • abcam.co.jp

      Join with us

      • LinkedIn
      • facebook
      • Twitter
      • YouTube
      • Terms of sale
      • Website terms of use
      • Cookie policy
      • Privacy policy
      • Legal
      • Modern slavery statement
      © 1998-2023 Abcam plc. All rights reserved.